Oral Delivery of Large Molecules

Investor

Overview

SEC Filing Details

Document Details

Form
3/A
Filing Date
Jul 25, 2022
Document Date
Jan 1, 2022
Form Description
An amendment to a 3 filing. Non-EDGAR filing
Filing Group
3,4,5
Company
Entera Bio Ltd.
Issuer
Entera Bio Ltd.
Filer
ELLIS SEAN